Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Promising clinical data for two small molecules targeting SARS-CoV-2 usher in era of antiviral drug that can be taken in outpatient and low-income settings.
Whether pan-vaccines or antibodies, SARS-CoV-2 is adding impetus to the race for broad-spectrum countermeasures against the world’s next infectious scourges.
India’s approval of a nucleic acid vaccine hints at a solution for low-income nations—if the limitations of current delivery technology can be overcome.
Lab-grown fish taste the same as their wild and farmed counterparts, offering an alternative to traditional seafood. But will it ever make economic sense to produce this kind of protein?
Life scientists are preparing to test quantum computers for applications beyond computational chemistry, such as selecting responders to cancer therapies.